Tue, July 17, 2018
Mon, July 16, 2018
Fri, July 13, 2018
Thu, July 12, 2018
Wed, July 11, 2018
Tue, July 10, 2018
Mon, July 9, 2018
Fri, July 6, 2018
Thu, July 5, 2018
Tue, July 3, 2018
Mon, July 2, 2018
Fri, June 29, 2018
Thu, June 28, 2018
Wed, June 27, 2018
Tue, June 26, 2018
Mon, June 25, 2018
Fri, June 22, 2018
Thu, June 21, 2018

M. Auster Maintained (BMRN) at Buy with Increased Target to $122 on, Jul 9th, 2018


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-122-on-jul-9th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

M. Auster of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $120 to $122 on, Jul 9th, 2018.

M. has made no other calls on BMRN in the last 4 months.



There are 4 other peers that have a rating on BMRN. Out of the 4 peers that are also analyzing BMRN, 0 agree with M.'s Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with M.


  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $133 on, Thursday, May 31st, 2018
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $115 on, Tuesday, May 29th, 2018
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $105 on, Friday, May 25th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $113 on, Monday, April 30th, 2018

Publication Contributing Sources